These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29286915)

  • 1. Upregulation of the long noncoding RNA FOXD2-AS1 predicts poor prognosis in esophageal squamous cell carcinoma.
    Bao J; Zhou C; Zhang J; Mo J; Ye Q; He J; Diao J
    Cancer Biomark; 2018 Feb; 21(3):527-533. PubMed ID: 29286915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous cell carcinoma and its correlation with tumor progression and patient survival.
    Wang YL; Bai Y; Yao WJ; Guo L; Wang ZM
    Int J Clin Exp Pathol; 2015; 8(9):11871-6. PubMed ID: 26617942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALAT1 might be a predictive marker of poor prognosis in patients who underwent radical resection of middle thoracic esophageal squamous cell carcinoma.
    Cao X; Zhao R; Chen Q; Zhao Y; Zhang B; Zhang Y; Yu J; Han G; Cao W; Li J; Chen X
    Cancer Biomark; 2015; 15(6):717-23. PubMed ID: 26406400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-Coding RNA FOXD2-AS1 Serves as a Potential Prognostic Biomarker for Patients With Cancer: A Meta-Analysis and Database Testing.
    Duan F; Li H; Liu W; Zhao J; Yang Z; Zhang J
    Am J Med Sci; 2021 Aug; 362(2):173-181. PubMed ID: 34303519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
    Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients].
    Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
    [No Abstract]   [Full Text] [Related]  

  • 7. High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Zhou XL; Wang WW; Zhu WG; Yu CH; Tao GZ; Wu QQ; Song YQ; Pan P; Tong YS
    Mol Carcinog; 2016 Dec; 55(12):2095-2105. PubMed ID: 26756568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis.
    Liu H; Zhang J; Luo X; Zeng M; Xu L; Zhang Q; Liu H; Guo J; Xu L
    Oncol Res; 2020 Feb; 28(1):65-73. PubMed ID: 31558183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein-coding genes combined with long non-coding RNAs predict prognosis in esophageal squamous cell carcinoma patients as a novel clinical multi-dimensional signature.
    Guo JC; Li CQ; Wang QY; Zhao JM; Ding JY; Li EM; Xu LY
    Mol Biosyst; 2016 Oct; 12(11):3467-3477. PubMed ID: 27714034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
    Tong YS; Zhou XL; Wang XW; Wu QQ; Yang TX; Lv J; Yang JS; Zhu B; Cao XF
    J Transl Med; 2014 Aug; 12():233. PubMed ID: 25169763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Role of a Novel Long Noncoding RNA
    Lin C; Zhang S; Wang Y; Wang Y; Nice E; Guo C; Zhang E; Yu L; Li M; Liu C; Hu L; Hao J; Qi W; Xu H
    Clin Cancer Res; 2018 Jan; 24(2):486-498. PubMed ID: 29101304
    [No Abstract]   [Full Text] [Related]  

  • 13. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Liu Z; Yang T; Xu Z; Cao X
    Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma.
    Shi WH; Wu QQ; Li SQ; Yang TX; Liu ZH; Tong YS; Tuo L; Wang S; Cao XF
    Tumour Biol; 2015 Apr; 36(4):2501-7. PubMed ID: 25731728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
    Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
    Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD2-AS1 acts an oncogene in esophageal squamous cell carcinoma through sponging miR-204-3p.
    Luo D; Salai A; Lv H; Wang Y; Gao Y
    Clin Transl Oncol; 2022 Oct; 24(10):1954-1963. PubMed ID: 35778646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of long non-coding RNA FOXD2-AS1 promotes progression and predicts poor prognosis in tongue squamous cell carcinoma.
    Zhou G; Huang Z; Meng Y; Jin T; Liang Y; Zhang B
    J Oral Pathol Med; 2020 Nov; 49(10):1011-1018. PubMed ID: 32531865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [FOXD2-AS1 is corelated with clinicopathological parameter of laryngeal carcinoma and promote cancer cell proliferation].
    Chen W; Sun SG; Jiang MX; Li SS; Yuan K
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 May; 33(5):436-440. PubMed ID: 31163553
    [No Abstract]   [Full Text] [Related]  

  • 20. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
    Tan J; Yang L
    Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.